THE LIVESTRONG FOUNDATION for THE LIVESTRONG FOUNDATION

Health Issues HCR

Accelerating Biomedical Research Act (S.2658/H.R. 5580), increased funding for NIH. Letter to the Food and Drug Administration on patient participation in medical product demonstration. Letter to the Department of HHS on benefits and payment parameters for 2016 insurance plans.

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 5580 (113th), S. 2658 (113th)

Medicare/Medicaid MMM

Letter to the Centers for Medicare and Medicaid Services about oncology care models.

Contacted: Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

HR 83: FY 2015 Omnibus; Consolidated and Further Continuing Appropriations Act - provisions related to NIH, NCI, and CDC funding for cancer programs/research.

Contacted: SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 83 (113th)

Taxation/Internal Revenue Code TAX

Supporting America's Charities Act (HR 5806), provisions related to deductions for charitable donations.

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE

Bills named: H.R. 5806 (113th)

Foreign Relations FOR

Healthcare systems and non-communicable disease funding globally; the PEPFAR Stewardship and Oversight Act of 2013 (S.1545/H.R.3177), provisions related to co-morbidities and AIDS-related cancers.

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: S. 1545 (113th), H.R. 3177 (113th)